Frontlight ResearchEarly access
Pancreatic cancer trials in France
117 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
- Where
- Clermont Ferrand Cedex1, Dijon, La Tronche, Lyon, Marseille, Nantes, Pessac, Toulouse Cedex 9, Vandoeuvre Les Nancy
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- Lumara Bio Oncologics GmbH
See details and how to joinNCT05706129 · EU 2023-504254-35-00 - Phase 2Taking peopleStudy Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance
- Where
- Bordeaux, Dijon, Marseille, Paris, Saint-Herblain, Vandœuvre-lès-Nancy, Villejuif
- Age
- 18 years and over
- People
- 60
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07483983 - Phase 1Taking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Lyon, Villejuif
- Age
- 18 years and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - Phase 1Taking peoplePhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Where
- Bron, Villejuif
- Age
- 18 years to 100 years
- People
- 162 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06562192 - Phase 1Taking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Bordeaux, Paris, Villejuif
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - Phase 1Taking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Villejuif
- Age
- 18 years and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - Phase 1Taking peopleA Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Where
- Lyon, Toulouse, Villejuif
- Age
- 18 years and over
- People
- 710 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06179160 · EU 2023-507091-47-00 - Phase 1Taking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Angers, Nice Cedex 2, Poitiers, Vandouvre Les Nancy, Villejuif
- Age
- 18 years and over
- People
- 1,006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - Phase 1/2Taking peopleA phase 1/2a, first-in-human, open-label, dose-escalating study with a safety expansion cohort to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary anti-tumour activity of TAX2 in patients with relapsed/refractory advanced/metastatic solid tumours
- Where
- Lyon, Villejuif
- Age
- 18 years and over
- People
- 48 worldwide
- Run by
- Apmonia Therapeutics
See details and how to join2025-521164-36-00 - No phaseTaking peopleAlpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer
- Where
- Bordeaux, Clermont-Ferrand, Dijon, Grenoble, Lyon, Marseille, Poitiers, Villejuif
- Age
- 18 years to 120 years
- People
- 40
- Run by
- Alpha Tau Medical LTD.
See details and how to joinNCT06755359 - No phaseNot yet taking people in FranceAssessment of SMI (Superb Microvascular Imaging) for Characterising the Endocystic Material of Papillary Intraductal Mucinous Pancreatic Tumours (PIMPT)
- Where
- Lyon
- Age
- 18 years and over
- People
- 60
- Run by
- GCS Ramsay Santé pour l'Enseignement et la Recherche
See details and how to joinNCT07663734 - No phaseTaking peopleDiscovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive Methodology
- Where
- Montpellier
- Age
- 18 years and over
- People
- 200
- Run by
- University Hospital, Montpellier
See details and how to joinNCT04370574 - No phaseTaking peopleLiquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC)
- Where
- Montpellier
- Age
- 18 years and over
- People
- 63
- Run by
- University Hospital, Montpellier
See details and how to joinNCT05346536 - No phaseTaking peopleNew Biomarkers in Pancreatic Cancer Using EXPEL Concept
- Where
- Montpellier
- Age
- 18 years and over
- People
- 200
- Run by
- University Hospital, Montpellier
See details and how to joinNCT03791073 - No phaseTaking peopleAssessment of the Usefulness of SMI (Superb Vascular Imaging) for the Characterisation of Pancreatic Cystic Tumours (IMAKYST)
- Where
- Lyon
- Age
- 18 years and over
- People
- 60
- Run by
- GCS Ramsay Santé pour l'Enseignement et la Recherche
See details and how to joinNCT07657884 - Phase 3Not yet taking people in FranceAdjuvant Trial in Pancreatic Neuroendocrine Tumors
- Where
- Villejuif
- Age
- 18 years and over
- People
- 300
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07591493 - Phase 1Not yet taking people in FranceStudy Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic Cancer
- Where
- Besançon, Dijon
- Age
- 18 years and over
- People
- 77
- Run by
- Centre Georges Francois Leclerc
See details and how to joinNCT07587827 - Phase 1/2SuspendedStudy Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
- Where
- Clichy, Nantes Cedex 1
- Age
- 18 years and over
- People
- 60
- Run by
- Nantes University Hospital
See details and how to joinNCT06735560 · EU 2023-508567-75-00 - Phase 1Taking peoplePhase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.
- Where
- Bron, Lyon Cedex 03, Pierre-Bénite, Villejuif
- Age
- 18 years and over
- People
- 76 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2023-510356-23-00 - No phaseTaking peopleImpact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
- Where
- Avignon, Rennes, Villejuif
- Age
- 18 years and over
- People
- 170
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07436312 - Phase 2Taking peopleFAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers
- Where
- Pessac
- Age
- 18 years and over
- People
- 120
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT07478523 - No phaseTaking peoplePATAKESS Protocol : Clinical and Biological Analysis of Exocrine Pancreatic Tumors
- Where
- Lyon
- Age
- 18 years and over
- People
- 300
- Run by
- Centre Leon Berard
See details and how to joinNCT04011982 - No phaseNot yet taking people in FranceSuperior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy
- Where
- Amiens, Angers, Besançon, Bordeaux, Clermont-Ferrand, Dijon, Lille, Limoges, Lyon, Montpellier, Nancy, Nantes, Paris, Rouen, Strasbourg, Toulouse, Villejuif
- Age
- 18 years and over
- People
- 150
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07547033 - No phaseTaking peopleConvertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma
- Where
- Bordeaux
- Age
- 18 years and over
- People
- 50
- Run by
- Institut Bergonié
See details and how to joinNCT06705335 - No phaseTaking peopleFunctional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB)
- Where
- Strasbourg
- Age
- 18 years and over
- People
- 60
- Run by
- IHU Strasbourg
See details and how to joinNCT06666803